Randomized trial: Budesonide orodispersible tablets maintain remission in patients with eosinophilic esophagitis

Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis – Gastroenterology

Editorial: Maintenance Topical Steroid Therapy in Eosinophilic Esophagitis: Not So Hard to Swallow Any More?

Commentary: Budesonide for Maintaining EoE Remission – gutsandgrowth

Commentary on Twitter

In a phase 3 trial, up to 48 weeks of treatment with BOT was superior to placebo in maintaining remission of #EoE https://t.co/vewrFYgIG9 pic.twitter.com/P1DzdWb2vH

— Gastroenterology (@AGA_Gastro) November 25, 2020